First Time Loading...
S

Singular Genomics Systems Inc
NASDAQ:OMIC

Watchlist Manager
Singular Genomics Systems Inc
NASDAQ:OMIC
Watchlist
Price: 0.4 USD
Updated: May 3, 2024

Singular Genomics Systems Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Singular Genomics Systems Inc
Operating Income Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Singular Genomics Systems Inc
NASDAQ:OMIC
Operating Income
-$100.9m
CAGR 3-Years
-54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Income
$7.3B
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Operating Income
$9.5B
CAGR 3-Years
20%
CAGR 5-Years
26%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Operating Income
$1.1B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Operating Income
$1.3B
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
16%
IQVIA Holdings Inc
NYSE:IQV
Operating Income
$2.1B
CAGR 3-Years
38%
CAGR 5-Years
21%
CAGR 10-Years
16%

See Also

What is Singular Genomics Systems Inc's Operating Income?
Operating Income
-100.9m USD

Based on the financial report for Dec 31, 2023, Singular Genomics Systems Inc's Operating Income amounts to -100.9m USD.

What is Singular Genomics Systems Inc's Operating Income growth rate?
Operating Income CAGR 3Y
-54%

Over the last year, the Operating Income growth was -8%. The average annual Operating Income growth rates for Singular Genomics Systems Inc have been -54% over the past three years .